← Evidence map

ReviewImmunoTargets and therapy2024

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.

Yuchen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38223406